Clinical Trials Logo

Genetic Diseases, Inborn clinical trials

View clinical trials related to Genetic Diseases, Inborn.

Filter by:

NCT ID: NCT05364294 Recruiting - Genetic Disease Clinical Trials

Molecular Diagnosis of Systemic Autoinflammatory Diseases

SAIDiag
Start date: May 18, 2022
Phase:
Study type: Observational

Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.

NCT ID: NCT05358964 Recruiting - Hereditary Diseases Clinical Trials

Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community

FHH
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

The understanding, utilization and uptake of Family Health History is essential to the prevention of health disparities in the African American community. Creating a culturally tailored Family Health History tool, co-developed by members of the African American community will inform, educate and empower African Americans about health issues related to their family genealogy. Applying the knowledge gained via Family Health Histories to increase preventative behaviors including screenings thus linking people to needed health services to prevent the onset of disease and illness.

NCT ID: NCT05356195 Recruiting - Clinical trials for Hematologic Diseases

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Start date: May 3, 2022
Phase: Phase 3
Study type: Interventional

This is a single-dose, open-label study in pediatric participants with TDT. The study will evaluate the safety and efficacy of autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells (hHSPCs) (CTX001).

NCT ID: NCT05339932 Recruiting - Cerebral Palsy Clinical Trials

Grand Valley State University (GVSU) Skills on Wheels

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

Manual wheelchairs (MWCs) are widely used by children with physical disabilities, yet many of these children are unable to use their wheelchair independently. Instead, they depend on others to push them. This dependency results in limited opportunities to decide what they want to do and where they want to go, leading to learned helplessness, social isolation, decreased participation, and restricted involvement in physical activities. Furthermore, unsafe MWC use increases the risk of injury, as highlighted by the 44,300 children treated each year in emergency departments for MWC-related injuries. While independent MWC mobility can positively influence quality of life, MWC skills training must also be provided to promote safe, independent MWC use. The effectiveness of MWC training programs for adults is well established, yet the current standard-of-care does not include MWC skills training for children and research regarding the efficacy of pediatric MWC skills training programs is limited. Skills on Wheels seeks to address these gaps and provide pilot data for a future large-scale, multi-site research project involving a randomized controlled trial. Aim 1 is to explore the influence of Skills on Wheels on children's MWC skills and confidence in their MWC use. Aim 2 is to investigate the influence of Skills on Wheels on children's psychosocial skills, social participation, and adaptive behavior.

NCT ID: NCT05305729 Recruiting - Genetic Disease Clinical Trials

Metabolic FingerPrinting

MetaPrint
Start date: March 1, 2021
Phase:
Study type: Observational

The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.

NCT ID: NCT05277116 Recruiting - Genetic Disease Clinical Trials

The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment

eMERGE
Start date: February 16, 2022
Phase: N/A
Study type: Interventional

The eMERGE Network embraces the opportunity to use new methods in genomic medicine, information science, and research participant engagement to identify people at very high risk for specific diseases and recommend individualized approaches to prevention and care. The investigators will conduct a prospective study, with diverse and underserved participants, across ten eMERGE study sites to evaluate clinical implementation of a Genome Informed Risk Assessment (GIRA) tool that combines genetic, family history, and clinical risk information from participants.

NCT ID: NCT05251467 Recruiting - Cystic Fibrosis Clinical Trials

A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF

CARDS-CF
Start date: February 28, 2022
Phase:
Study type: Observational

Development of a new patient reported outcome measure (PROM) that will measure the daily burden of gastrointestinal symptoms over the previous 24 hour period for people with cystic fibrosis.

NCT ID: NCT05238519 Recruiting - Genetic Disease Clinical Trials

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

ID-FH
Start date: February 15, 2022
Phase: Phase 3
Study type: Interventional

The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to receive usual care or motivational interview. Primary study outcomes include knowledge of FH, as well as clinical and patient-reported outcomes. This study aims to promote optimal disease management and improve outcomes of FH patients.

NCT ID: NCT05227066 Recruiting - Clinical trials for Ataxic Cerebral Palsy

Efficacy of Adding Lower Extremity Weights on Balance in Children With Ataxic Cerebral Palsy

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Ataxic CP is one type of cerebral palsy. children with ataxic cerebral palsy have trouble with balance and coordination. They may walk with their legs farther apart than other kids and have a hard time with activities that use small hand movements, like writing. Some also have trouble with depth perception This means being able to accurately judge how close or far away something is

NCT ID: NCT05216068 Recruiting - Clinical trials for Recurrent Miscarriage

Investigation and Diagnosis of the Chromosome Variation in Donated/Abandoned Blastocyst

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Blastocysts derived from patients seeking infertility treatment were generated by in vitro fertilization and embryo culture as previously described, and were evaluated using the Gardner system. As part of the embryo selection process, cells of TE biopsy were collected, and blastocysts were vitrified. The clinical TE biopsies were subjected to whole genome amplification (WGA) with SurePlex reagents (Illumina) followed by NGS-based PGT-A using Illumina's VeriSeq kit (Illumina) on a MiSeq system (Illumina) according to the manufacturer's protocol.